NATALIE GARDINIER: Open Payments
NPI 1417677089 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,948 in 115 payments from 14 companies in 2025. Trend: 2023 $640 · 2024 $2,771 · 2025 $4,948
Food & beverage: $3,425Consulting: $1,233Education: $290
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $1,640 |
| Janssen Biotech, Inc. | 42 | $1,054 |
| Novartis Pharmaceuticals Corporation | 15 | $569 |
| ABBVIE INC. | 10 | $339 |
| Galderma Laboratories, L.P. | 21 | $311 |
| UCB, Inc. | 6 | $256 |
| Arcutis Biotherapeutics, Inc. | 5 | $197 |
| Organon LLC | 2 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $105 |
| Amgen Inc. | 1 | $98 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, Zoryve, COSENTYX, RINVOQ, Rhapsido.
Industry payments across PA — which companies pay providers there.
